On Thursday 27th March, some of our team attended a networking event hosted by Quotient Sciences, a Small Molecule & Peptide CDMO, at the Oxford Malmaison Hotel.
During the event, John McDermott (Vice President of Scientific Consulting at Quotient Sciences) presented on how Translational Pharmaceutics® enhances drug development by addressing key challenges in preclinical and clinical testing.
It was an insightful event, and the team had the opportunity to meet some very interesting people.